Sun Pharmaceutical Industries announced on Tuesday that it has launched a medication in the country to treat dry eye disease. The Mumbai-based pharmaceutical company announced the launch of Cequa, a novel ophthalmology treatment for patients....
Johnson & Johnson said on Monday that its consumer health unit, Kenvue, would seek a valuation of up to $42.95 billion in its initial public offering, at a time when investor appetite for new listings has been muted. The announcement sets the....
The IHW Council, India's premier think-tank for preventive and promotive health, has launched the Spirituality for Health & Environment Alliance (SHE-Alliance), which aims to empower women in society to take the lead on health transformation of ...
Zydus Lifesciences on Monday said it has received approval from the US health regulator to market a generic medication that is used to lower triglycerides, in the American market.The company has got the final approval from the US Food and Drug A...
Scott Smith, M.D., Ph.D. has been named senior vice president, global therapeutic area head - haematology at Parexel, one of the world's largest CROs providing a full range of phase I to IV clinical development services. Dr. Smith will be ...
Aptitude Medical Systems (Aptitude) announced a $53.7 million award from the Biomedical Advanced Research and Development Authority (BARDA), which is part of the Administration for Strategic Preparedness and Response within the US Department...
We are rapidly transitioning into an era where software platforms will be treating millions of patients, - thanks to the huge advancements in digital health innovation
The three-day initial public offering (IPO) will be offered for subscription on April 25-27, with bidding for anchor investors beginning on April 24. Mankind Pharma's initial public offering is scheduled to begin trading next week, with a price...
Artificial Intelligence (AI) is transforming the healthcare industry in many ways, and drug discovery is no exception. AI has the potential to revolutionize drug discovery by increasing the efficiency and accuracy of the process.
China's pharmaceutical firm Hasten Biopharmaceutic has raised $315 million in a fundraising round co-led by Asia's largest healthcare investment firm CBC Group and Abu Dhabi sovereign wealth fund Mubadala Investment Company....
, CDSCO.jpg)
.jpg)